Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • NORTH AMERICA MEDICAL ENZYMES MARKET FORECAST 2022-2030

NORTH AMERICA MEDICAL ENZYMES MARKET FORECAST 2022-2030

The North America medical enzymes market is estimated to grow with a CAGR of 6.34% over the forecasted years of 2022 to 2030, acquiring a revenue share of $2888.99 million by 2030.

NORTH AMERICA MEDICAL ENZYMES MARKET FORECAST 2022-2030

North America Medical Enzymes Market by Type (Hydrolase (Hyaluronidase, Lysozymes, Other Hydrolases Enzymes), Thrombolytic (Streptokinase, Urokinase, Other Thrombolytic Enzymes), Digestive Enzyme (Lactase, L-asparaginase, Other Digestive Enzymes), Endonuclease (Benzonase, Other Endonucleases)) Market by Application ( Disease Treatment, Diagnostic Tools, Biomedical Research, Other Applications)

Request free sample

Report Summary

The North America medical enzymes market is estimated to grow with a CAGR of 6.34% over the forecasted years of 2022 to 2030, acquiring a revenue share of $2888.99 million by 2030.

The increasing number of chronic conditions, the growing investments in research and development, the rise in enzyme therapies, and the surging awareness about health as well as food and supplements are among the key factors accredited to the growth of the regional market. However, the healthcare and medical reimbursement policies in the region may hamper the North America medical enzymes market’s growth.

North America Medical Enzymes Market

To know more about this report, request a free sample copy

The North America medical enzymes market growth evaluation constitutes the analysis of the United States and Canada. Technological innovations in terms of obtaining enzymes, the extensive research activities, and the increasing concerns associated with health and personal care primarily fuel the demand for medical enzymes in the United States. Moreover, the country’s consumption of probiotics via dietary supplements is high, as well. As a result, the United States observes an increase in consumption of digestive health ingredients, primarily owing to health consciousness.

On the other hand, the presence of market players in the country, in addition to the partnerships, product launches, as well as collaborations initiated by these companies, further fuel the market’s growth. For instance, Nestle Health Science and Codexis entered a collaboration for the discovery of new enzyme therapies for treating gastrointestinal disorders.

Conversely, in Canada, technological advancements play an essential role in fueling the demand and application of medical enzymes. Moreover, larger enzyme manufacturing capacity, combined with robust investments in enzyme developments, significantly contributes to the Canadian market, as well. Hence, these factors are set to propel the North America medical enzymes market growth over the forecast period.

The North America medical enzymes market is segmented into type and application. The type category is further segmented into hydrolase, thrombolytic enzyme, digestive enzyme, and endonuclease. The growth of the hydrolase segment is mainly accredited to its applications for digestive action. Since hydrolase is utilized to break down nutrients into smaller units for improved digestion, the market is expected to progress owing to the increase in gastrointestinal problems as well as other health issues. Hydrolases also perform as biochemical catalysts that use water for breaking down a chemical bond, resulting in the division of a bigger molecule into relatively smaller molecules.

In comparison, thrombolytic enzymes possess the potential to dissolve blood clots while preventing any adverse effects. Thrombolytic drugs are used to dissolve blood clots by activating plasminogen, resulting in a cleaved product called plasmin. Hence, their use as a potential thrombolytic therapy has gained substantial prominence in the market

Some of the leading companies in the North America medical enzymes market include Novus, DuPont, Codexis, etc.

Novus, headquartered in the United States, manufactures and commercializes health and nutrition solutions for livestock, poultry, and aquaculture. The company has two research facilities and four manufacturing units, with sales offices across the world. Novus primarily offers products for swine, beef, poultry, dairy, and aqua species, in addition to high quality trace minerals.

The company’s Enzyme Solutions are used for supporting a healthy digestive system and promoting efficient meat production.

Report Synopsis

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Product and Application
Countries Analyzed The United States and Canada
Companies Analyzed

BASF, DuPont, Roche Holding, Novozymes, DSM, Sanofi, Codexis, Novus, BRAIN, Sekisui, Advanced Enzymes, Amano Enzyme, BBI Solutions, Thermo Fisher Scientific, CPC Biotech

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Table of Contents

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • INCREASED INVESTMENT IN HEALTHCARE RESEARCH AND FACILITIES
        • WIDENING APPLICATION IN MEDICAL INDUSTRY
        • GROWING PREVALENCE OF CHRONIC DISEASES AND RISING AGING POPULATION
      • KEY RESTRAINTS
        • HANDLING AND SAFETY OF ENZYMES
        • REGULATIONS FOR MEDICAL ENZYMES
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON MEDICAL ENZYMES MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
        • RESEARCH AND DEVELOPMENT
        • OPERATIONS
        • OUTBOUND LOGISTICS
      • KEY BUYING CRITERIA
        • COST
        • QUALITY
        • APPLICATION
      • REGULATORY FRAMEWORK
    2. MARKET BY TYPE
      • HYDROLASE
        • HYALURONIDASE
        • LYSOZYMES
        • OTHER HYDROLASES ENZYMES
      • THROMBOLYTIC
        • STREPTOKINASE
        • UROKINASE
        • OTHER THROMBOLYTIC ENZYMES
      • DIGESTIVE ENZYME
        • LACTASE
        • L-ASPARAGINASE
        • OTHER DIGESTIVE ENZYMES
      • ENDONUCLEASE
        • BENZONASE
        • OTHER ENDONUCLEASES
    1. MARKET BY APPLICATION
      • DISEASE TREATMENT
      • DIAGNOSTIC TOOLS
      • BIOMEDICAL RESEARCH
      • OTHER APPLICATIONS
    2. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • ADVANCED ENZYMES
        • AMANO ENZYME
        • BASF
        • BBI SOLUTIONS
        • BRAIN
        • CODEXIS
        • CPC BIOTECH
        • DSM
        • DUPONT
        • NOVOZYMES
        • NOVUS
        • ROCHE
        • SANOFI
        • SEKISUI
        • THERMO FISHER SCIENTIFIC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – MEDICAL ENZYMES

    TABLE 2: MEDICAL APPLICATION OF VARIOUS ENZYMES

    TABLE 3: APPLICATIONS OF ENZYMES IN PHARMACEUTICALS INDUSTRY

    TABLE 4: REGULATORY FRAMEWORK

    TABLE 5: NORTH AMERICA MEDICAL ENZYMES MARKET, BY TYPE, HISTORICAL YEARS 2018-2021 (IN $ MILLION)

    TABLE 6: NORTH AMERICA MEDICAL ENZYMES MARKET, BY TYPE, FORECAST YEARS 2022-2030 (IN $ MILLION)

    TABLE 7: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, HISTORICAL YEARS 2018-2021 (IN $ MILLION)

    TABLE 8: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, FORECAST YEARS 2022-2030 (IN $ MILLION)

    TABLE 9: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, HISTORICAL YEARS 2018-2021 (IN $ MILLION)

    TABLE 10: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, FORECAST YEARS 2022-2030 (IN $ MILLION)

    TABLE 11: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, HISTORICAL YEARS 2018-2021 (IN $ MILLION)

    TABLE 12: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, FORECAST YEARS 2022-2030 (IN $ MILLION)

    TABLE 13: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, HISTORICAL YEARS 2018-2021 (IN $ MILLION)

    TABLE 14: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, FORECAST YEARS 2022-2030 (IN $ MILLION)

    TABLE 15: NORTH AMERICA MEDICAL ENZYMES MARKET, BY APPLICATION, HISTORICAL YEARS 2018-2021 (IN $ MILLION)

    TABLE 16: NORTH AMERICA MEDICAL ENZYMES MARKET, BY APPLICATION, FORECAST YEARS 2022-2030 (IN $ MILLION)

    TABLE 17: NORTH AMERICA MEDICAL ENZYMES MARKET, BY COUNTRY, HISTORICAL YEARS 2018-2021 (IN $ MILLION)

    TABLE 18: NORTH AMERICA MEDICAL ENZYMES MARKET, BY COUNTRY, FORECAST YEARS 2022-2030 (IN $ MILLION)

    TABLE 19: LEADING PLAYERS OPERATING IN NORTH AMERICA MEDICAL ENZYMES MARKET

    TABLE 20: LIST OF MERGERS & ACQUISITIONS

    TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 22: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 23: LIST OF BUSINESS EXPANSIONS & DIVESTITURES          

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: VALUE CHAIN ANALYSIS

    FIGURE 6: KEY BUYING CRITERIA

    FIGURE 7: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021

    FIGURE 8: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2030 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY HYDROLASE ENZYME, IN 2021

    FIGURE 10: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2030 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2030 (IN $ MILLION)

    FIGURE 12: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2030 (IN $ MILLION)

    FIGURE 13: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)

    FIGURE 14: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY THROMBOLYTIC ENZYME, IN 2021

    FIGURE 15: NORTH AMERICA MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2030 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2030 (IN $ MILLION)

    FIGURE 17: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)

    FIGURE 18: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2030 (IN $ MILLION)

    FIGURE 19: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY DIGESTIVE ENZYME, IN 2021

    FIGURE 20: NORTH AMERICA MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2030 (IN $ MILLION)

    FIGURE 21: NORTH AMERICA MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2030 (IN $ MILLION)

    FIGURE 22: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2030 (IN $ MILLION)

    FIGURE 23: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2030 (IN $ MILLION)

    FIGURE 24: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY ENDONUCLEASE, IN 2021

    FIGURE 25: NORTH AMERICA MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2030 (IN $ MILLION)

    FIGURE 26: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2030 (IN $ MILLION)

    FIGURE 27: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021

    FIGURE 28: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2030 (IN $ MILLION)

    FIGURE 29: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2030 (IN $ MILLION)

    FIGURE 30: NORTH AMERICA MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2030 (IN $ MILLION)

    FIGURE 31: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)

    FIGURE 32: NORTH AMERICA MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021& 2030 (IN %)

    FIGURE 33: UNITED STATES MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 34: CANADA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)       

    SEGMENTATION

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY TYPE
      • HYDROLASE
        • HYALURONIDASE
        • LYSOZYMES
        • OTHER HYDROLASES ENZYMES
      • THROMBOLYTIC
        • STREPTOKINASE
        • UROKINASE
        • OTHER THROMBOLYTIC ENZYMES
      • DIGESTIVE ENZYME
        • LACTASE
        • L-ASPARAGINASE
        • OTHER DIGESTIVE ENZYMES
      • ENDONUCLEASE
        • BENZONASE
        • OTHER ENDONUCLEASES
    1. MARKET BY APPLICATION
      • DISEASE TREATMENT
      • DIAGNOSTIC TOOLS
      • BIOMEDICAL RESEARCH
      • OTHER APPLICATIONS

    Request Free Sample

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      RELATED REPORTS

      Author: Inkwood Research